347740 — P&K Skin Research Center Co Share Price
- KR₩64bn
- KR₩24bn
- KR₩18bn
- 89
- 62
- 51
- 79
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.83 | ||
Price to Tang. Book | 0.84 | ||
Price to Free Cashflow | 7.62 | ||
Price to Sales | 3.59 | ||
EV to EBITDA | 5.38 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 3.34% | ||
Return on Equity | 7.7% | ||
Operating Margin | 14.47% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | KR₩m | 14,676.38 | 17,487.13 | 17,957.2 | 14,842.6 | 17,846.81 | n/a | n/a | 7.38% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +17.9 | -5.27 | -2.86 | -32.9 | +24.84 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
P&K Skin Research Center Co Ltd a Korea-based company mainly engaged in the business of skin human application testing. The Company provides services such as human application testing, safety tests, cosmetic efficacy tests, cosmeceuticals tests, health food tests, sensory tests, and in vitro tests. In addition, the Company perform scientific evaluations of efficacy for products applied to human skin to provide information about the products and technical support.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- October 7th, 2010
- Public Since
- September 9th, 2020
- No. of Shareholders
- 9,732
- No. of Employees
- 104
- Sector
- Professional & Commercial Services
- Industry
- Industrials
- Exchange
Korea Exchange - KOSDAQ
- Shares in Issue
- 28,881,791

- Address
- 4F, Education Facility Dsstr Asctn Bldg, SEOUL, 07236
- Web
- http://www.pnkskin.com/
- Phone
- +82 269251502
- Auditors
- Ernst & Young Han Young
Upcoming Events for 347740
Similar to 347740
Airrane Co
Korea Exchange - KOSDAQ
Catis
Korea Exchange - KOSDAQ
Clean & Science Co
Korea Exchange - KOSDAQ
CNT85
Korea Exchange - KOSDAQ
Danal Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 22:39 UTC, shares in P&K Skin Research Center Co are trading at KR₩2,220. This share price information is delayed by 15 minutes.
Shares in P&K Skin Research Center Co last closed at KR₩2,220 and the price had moved by -23.92% over the past 365 days. In terms of relative price strength the P&K Skin Research Center Co share price has underperformed the FTSE Developed Asia Pacific Index by -23.06% over the past year.
The overall consensus recommendation for P&K Skin Research Center Co is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe P&K Skin Research Center Co dividend yield is 1.8% based on the trailing twelve month period.
Last year, P&K Skin Research Center Co paid a total dividend of KR₩40, and it currently has a trailing dividend yield of 1.8%. We do not have any data on when P&K Skin Research Center Co is to next pay dividends.
We do not have data on when P&K Skin Research Center Co is to next pay dividends. The historic dividend yield on P&K Skin Research Center Co shares is currently 1.8%.
To buy shares in P&K Skin Research Center Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩2,220, shares in P&K Skin Research Center Co had a market capitalisation of KR₩64bn.
Here are the trading details for P&K Skin Research Center Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 347740
Based on an overall assessment of its quality, value and momentum P&K Skin Research Center Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in P&K Skin Research Center Co is KR₩37,167. That is 1574.21% above the last closing price of KR₩2,220.
Analysts covering P&K Skin Research Center Co currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like P&K Skin Research Center Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -1.4%.
As of the last closing price of KR₩2,220, shares in P&K Skin Research Center Co were trading -6.82% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The P&K Skin Research Center Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩2,220.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on P&K Skin Research Center Co's directors